
Nanox is trying to turn Zebra Medical Vision’s scan-reading software into a hospital business, not just an AI demo. The company said it had accelerated work around Nanox.AI, added Cedars-Sinai as a clinical-trial partner for an aortic valve calcification tool and pushed U.S. deployment of Nanox.ARC systems, with Chief Executive Erez Meltzer calling the fourth quarter “strong momentum.”
Today’s highest-ranked model selections.
The catalysts most likely to move markets.
The 9:45 AM ET pair has the strongest broad-market potential today because growth surprises can quickly reprice Treasury yields, the dollar and rate expectations.
Results can influence consumer and retail sentiment, particularly around value-seeking behavior, traffic and gross margins.
Its results are relevant for communications equipment and networking demand, with earnings sensitivity to margins and product mix.